» Articles » PMID: 12671149

School-age Outcomes of Very Low Birth Weight Infants in the Indomethacin Intraventricular Hemorrhage Prevention Trial

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2003 Apr 3
PMID 12671149
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The cohort consisted of 328 very low birth weight infants (600-1250 g birth weight) who were enrolled in the low-dose prophylactic indomethacin prevention trial and were intraventricular hemorrhage (IVH) negative at 6 postnatal hours. The objective was to determine the effects of both IVH and indomethacin on cognitive, language, and achievement performance at 8 years of age.

Methods: The cohort was divided into 4 subgroups for analysis: indomethacin plus IVH, indomethacin no IVH, saline plus IVH, and saline with no IVH. The children were evaluated prospectively at 8 years of age with a neurologic assessment, history of school performance, and a battery of cognitive, academic, behavioral, and functional assessments.

Results: Children in both IVH groups had more cerebral palsy; more hearing impairment; lower daily living skills scores; lower IQ, vocabulary, and reading and mathematics achievement test scores; and greater educational resource needs. With logistic regression analyses grade 3 to 4 IVH, periventricular leukomalacia and/or ventriculomegaly, male gender, maternal education, and language spoken in the home contributed to outcomes. No effects of indomethacin or gestational age were identified.

Conclusions: Although biological factors including IVH, ventriculomegaly, and periventricular leukomalacia contribute significantly to school age outcomes among very low birth weight survivors at 8 years of age, social and environmental factors including maternal level of education and primary language spoken in the home are also important contributors to outcome.

Citing Articles

Long-term outcomes of very low birth weight infants with intraventricular hemorrhage: a nationwide population study from 2011 to 2019.

Park J, Park S, Kwon Y, Yoon S, Lim J, Han J World J Pediatr. 2024; 20(7):692-700.

PMID: 38615088 PMC: 11269332. DOI: 10.1007/s12519-024-00799-x.


Reduced racial disparities among newborns with intraventricular hemorrhage.

Sayeed S, Reeves B, Theriault B, Hengartner A, Ahsan N, Sadeghzadeh S Childs Nerv Syst. 2024; 40(7):2051-2059.

PMID: 38526575 DOI: 10.1007/s00381-024-06369-w.


A systematic review of immune-based interventions for perinatal neuroprotection: closing the gap between animal studies and human trials.

Kelly S, Tran N, Polglase G, Hunt R, Nold M, Nold-Petry C J Neuroinflammation. 2023; 20(1):241.

PMID: 37864272 PMC: 10588248. DOI: 10.1186/s12974-023-02911-w.


Photostimulation of brain lymphatics in male newborn and adult rodents for therapy of intraventricular hemorrhage.

Li D, Liu S, Yu T, Liu Z, Sun S, Bragin D Nat Commun. 2023; 14(1):6104.

PMID: 37775549 PMC: 10541888. DOI: 10.1038/s41467-023-41710-y.


Reading impairment after neonatal hypoglycemia with parieto-temporo-occipital injury without cortical blindness: A case report.

Kurahashi N, Ogaya S, Maki Y, Nonobe N, Kumai S, Hosokawa Y World J Clin Cases. 2023; 11(16):3899-3906.

PMID: 37383118 PMC: 10294167. DOI: 10.12998/wjcc.v11.i16.3899.